Ledger.Open graph →
SEC Form D · filed March 10, 2016

Aspyrian Therapeutics, Inc

Offering
$45.0M
Sold
$40.0M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
SAN DIEGO, CA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (10)

Merrill Biel · San Diego, CAExec · DirectorMiguel Garcia-Guzman · San Diego, CAExec · DirectorHiroshi Mikitani · New York, NYDirectorHiroshi Mori · San Diego, CADirectorSamuel Ulloa · San Francisco, CAExec · DirectorHarry Aurora · Jericho, NYExec · DirectorDaniel Carroll · San Francisco, CAExec · DirectorSensato Investors LLC · San Francisco, CAExec · DirectorHiroshi Mikitani · San Diego, CADirectorHiroshi Mori · San Diego, CADirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗